Trump calls for Fed Governor Cook’s resignation over mortgage probe
Cardinal Health (NYSE:CAH), a prominent healthcare provider with a market capitalization of $35.6 billion, saw its Chief Executive Officer Jason M. Hollar sell a total of $16.04 million in company shares on August 19, 2025. The stock, which has delivered a 38% return over the past year, is currently trading below its InvestingPro Fair Value. The sales were executed in multiple transactions with prices ranging from $148.15 to $149.45.
According to a Form 4 filing with the Securities and Exchange Commission, Hollar sold 6,657 shares at a weighted average price of $148.15, 94,735 shares at a weighted average price of $148.92, and 6,313 shares at a weighted average price of $149.45.
On August 15, Hollar also acquired 42,778 shares of Common Stock with a value of $0, and disposed of 136,407 shares for $20.49 million to cover tax obligations related to vesting restricted share units and performance share units. For deeper insights into Cardinal Health’s valuation metrics and 11 additional exclusive ProTips, visit InvestingPro.
In other recent news, Cardinal Health reported its fourth-quarter earnings for fiscal 2025, revealing a mixed financial performance. The company achieved earnings per share of $2.08, slightly exceeding the expected $2.03. However, revenue came in at $60.2 billion, missing the forecasted $60.92 billion. In addition, Cardinal Health announced a $1 billion notes offering in two tranches, consisting of $600 million of 4.500% notes due 2030 and $400 million of 5.150% notes due 2035. This offering is being conducted under the company’s existing shelf registration statement with Goldman Sachs, BofA Securities, and Wells Fargo (NYSE:WFC) Securities acting as underwriters. Furthermore, Cardinal Health’s Board of Directors has approved a quarterly dividend of $0.5107 per share, payable to shareholders of record as of October 1, 2025. These developments reflect Cardinal Health’s ongoing financial and strategic activities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.